RETRACTED ARTICLE: Direct transfer of STEMI patients to cardiac catheterization laboratory

• Published in: Herz Vol. 44; no. 5; p. 460
• Main Authors: Ali, M, Lange, S A, Wittlinger, T, Lehnert, G, Behrend, S, Ziadeh, B, Ali, K, Sakellaropoulos, S, Ganchev, G, Rigopoulos, A G, Noutsias, M
• Format: Journal Article
• Language: English
• Published: Munich Springer Nature B.V 01.08.2019
• ISSN: 0340-9937; 1615-6692
• DOI: 10.1007/s00059-017-4673-z

BackgroundAlthough the incidence of acute myocardial infarction and in-hospital mortality after ST-elevation myocardial infarction (STEMI) has declined substantially in countries that have established primary percutaneous coronary interventions (pPCI) over the past two decades, coronary artery disease remains a major cause of morbidity and mortality worldwide. We aimed to examine whether the direct transfer of STEMI patients to the cardiac catheterization laboratory (CCL) had a prognostic effect on in-hospital mortality in patients who underwent pPCI after STEMI.MethodsThe in-house mortality of STEMI patients who underwent pPCI was assessed at the Department of Cardiology, Harzklinik Goslar, Germany, between April 2013 and June 2017.ResultsWe enrolled 312 STEMI patients, with a mean age of 67.1 ± 13.4 years, of whom 211 (71%) were male. The all-cause in-hospital mortality was 10% (n = 31 patients). A total of 298 (95%) patients were directly transferred to the CCL. while 14 patients (5%) with STEMI were not directly transferred to the CCL (tCCL) but were taken to the emergency department (tED). In the tCCL group, 18 patients (6%) died during the hospital stay, compared with 11 patients (79%) in the tED STEMI group; thus, the in-hospital mortality rate was significantly higher (p < 0.0001) in the tED group.ConclusionOur monocentric cohort highlights and confirms the clinical importance of the direct transfer of patients with STEMI to the CCL. This approach is associated with a significant decrease in in-hospital mortality as compared with the tED approach.